These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 27405364)
1. ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen® "Amphetamine" and "Methamphetamine/MDMA" Kits. Nieddu M; Burrai L; Baralla E; Pasciu V; Varoni MV; Briguglio I; Demontis MP; Boatto G J Anal Toxicol; 2016 Sep; 40(7):492-7. PubMed ID: 27405364 [TBL] [Abstract][Full Text] [Related]
2. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine. Apollonio LG; Whittall IR; Pianca DJ; Kyd JM; Maher WA J Anal Toxicol; 2007 May; 31(4):208-13. PubMed ID: 17555644 [TBL] [Abstract][Full Text] [Related]
3. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530 [TBL] [Abstract][Full Text] [Related]
4. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS. Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639 [TBL] [Abstract][Full Text] [Related]
5. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood. Gjerde H; Langel K; Favretto D; Verstraete AG Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911 [TBL] [Abstract][Full Text] [Related]
6. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device. Röhrich J; Zörntlein S; Becker J; Urban R J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540 [TBL] [Abstract][Full Text] [Related]
7. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine. Stout PR; Klette KL; Wiegand R J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938 [TBL] [Abstract][Full Text] [Related]
8. Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine. Kupiec T; DeCicco L; Spiehler V; Sneed G; Kemp P J Anal Toxicol; 2002 Oct; 26(7):513-8. PubMed ID: 12423009 [TBL] [Abstract][Full Text] [Related]
9. Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation. Di Rago M; Chu M; Rodda LN; Jenkins E; Kotsos A; Gerostamoulos D Anal Bioanal Chem; 2016 May; 408(14):3737-49. PubMed ID: 26993306 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a rapid oral fluid point-of-care test for MDMA. Wilson L; Jehanli A; Hand C; Cooper G; Smith R J Anal Toxicol; 2007 Mar; 31(2):98-104. PubMed ID: 17536745 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS. Maresová V; Chadt J; Prikryl L Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795 [TBL] [Abstract][Full Text] [Related]
12. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. Hsu J; Liu C; Liu CP; Tsay WI; Li JH; Lin DL; Liu RH J Anal Toxicol; 2003 Oct; 27(7):471-8. PubMed ID: 14607002 [TBL] [Abstract][Full Text] [Related]
13. False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol-two cases reported in clinical toxicology. Leclercq M; Soichot M; Delhotal-Landes B; Bourgogne E; Gourlain H; Mégarbane B; Labat L J Anal Toxicol; 2020 Mar; 44(2):200-205. PubMed ID: 31384953 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of commercial multi-drug oral fluid devices to identify 39 new amphetamine-designer drugs. Nieddu M; Burrai L; Trignano C; Boatto G Leg Med (Tokyo); 2014 Mar; 16(2):106-9. PubMed ID: 24360925 [TBL] [Abstract][Full Text] [Related]
15. The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion. Krotulski AJ; Mohr ALA; Fogarty MF; Logan BK J Anal Toxicol; 2018 Oct; 42(8):544-553. PubMed ID: 30371847 [TBL] [Abstract][Full Text] [Related]
16. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS. Wood M; De Boeck G; Samyn N; Morris M; Cooper DP; Maes RA; De Bruijn EA J Anal Toxicol; 2003 Mar; 27(2):78-87. PubMed ID: 12670001 [TBL] [Abstract][Full Text] [Related]
17. Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis. Chen C; Kostakis C; Harpas P; Felgate PD; Irvine RJ; White JM J Stud Alcohol Drugs; 2011 Sep; 72(5):737-40. PubMed ID: 21906501 [TBL] [Abstract][Full Text] [Related]